TAMPA, Fla. & YORK, England--(BUSINESS WIRE)--UTEK Corporation (AMEX:UTK) (LSE-AIM:UTK), an open innovation company focused on technology transfer, has agreed to acquire Pharmalicensing, Ltd. through its subsidiary UTEK Europe, Ltd. Pharmalicensing is a leading open innovation service for partnering, licensing and business development within the life science and biopharmaceutical industry.
